BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Galectin Therapeutics Announces $10 Million Credit Line from Richard E. Uihlein Sufficient to Cover Expected Expenditures Into 2019

  Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced it entered into a $10M unsecured line of credit facility with stockholder and new director Richard E. Uihlein.

  December 20, 2017

   · 

  8 min read
• Drug Development

  AIVITA Biomedical Announces First Patient Enrolled in Phase II Clinical Trial for Late-Stage Ovarian Cancer

  AiVita Biomedical today announced that the first patient has been enrolled in its double-blind Phase II clinical study assessing the efficacy and safety of its autologous cancer immunotherapy in women with advanced epithelial ovarian carcinomas.

  December 20, 2017

   · 

  2 min read
• Pharm Country

  ProPhase Labs Announces Preliminary Results of its Tender Offer

  ProPhase Labs announced today the preliminary results of its tender offer to purchase up to 1,700,000 shares of its common stock at a price of $2.30 per share, which expired at midnight, New York City time, on December 18, 2017.

  December 20, 2017

   · 

  4 min read
• BioCapital

  K2M Introduces World’s First 3D-Printed Expandable Corpectomy Cage With Cervical Spine Indications Following CE Mark of CAPRI Cervical 3D Expandable Featuring Lamellar 3D Titanium Technology

  The CAPRI Cervical 3D Expandable Cage System stabilizes the cervical spine in cases of vertebral body resections resulting from trauma or tumor.

  December 20, 2017

   · 

  10 min read
• Sirona Biochem Announces Results of AGM & CEO Update

  Sirona Biochem announces that all resolutions tabled at its Annual General Meeting held on December 18, 2017, were passed.

  December 20, 2017

   · 

  5 min read
• PENTAX Medical Highlights New Products Supporting Total Approach to Disease Management at UEGW 2017

  PENTAX Medical highlights how it has developed a range of screening, diagnostic and therapeutic endoscopic solutions for the complete management of the most common conditions encountered by healthcare providers.

  December 20, 2017

   · 

  4 min read
• Business

  TiGenix Confirms Strategic Focus on Cx601 and its Adipose Derived Stem Cell (eASC) Platform

  This decision follows the recent positive CHMP opinion for Cx601 to treat complex perianal fistulas in Crohn’s disease.

  December 20, 2017

   · 

  9 min read
• Titan Medical Reports First Use of SPORT Surgical System in Europe at the Institute of Image-Guided Surgery of Strasbourg

  TITAN Medical reports the successful first use of its SPORT Surgical System in Europe.

  December 20, 2017

   · 

  6 min read
• Drug Development

  Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation by U.S. FDA for Treatment of Lennox-Gastaut Syndrome

  Takeda and Ovid formed a global collaboration in January 2017 to develop and commercialize TAK-935/OV935 for the treatment of developmental and epileptic encephalopathies

  December 20, 2017

   · 

  7 min read
• Business

  BioDelivery Sciences Appoints Scott Plesha to President

  BioDelivery announced the appointment of Scott Plesha, currently Senior VP of Sales and Marketing at BDSI, to the role of President, effective January 2, 2018.

  December 20, 2017

   · 

  4 min read